PGI34 - A COST SAVING MEASURE FROM THE UTILISATION OF BIOSIMILAR INFLIXIMAB IN THE IRISH SECONDARY CARE SETTING

Mark Mulcahy

doi:10.1016/j.jval.2018.09.876

PGI34 - A COST SAVING MEASURE FROM THE UTILISATION OF BIOSIMILAR INFLIXIMAB IN THE IRISH SECONDARY CARE SETTING

Mark Mulcahy

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Value in Health
DOIs	https://doi.org/10.1016/j.jval.2018.09.876
Publication status	Published - 2018

Keywords

Biosimilar
Infliximab
Medicine
Irish
Health care
Actuarial science
Business
Disease
Economics
Internal medicine
Linguistics
Philosophy
Economic growth

Access to Document

10.1016/j.jval.2018.09.876

https://openalex.org/W2905793341Licence: CC BY-NC-ND

Cite this

@article{56750d3a922e459197c8fd82e281887f,

title = "PGI34 - A COST SAVING MEASURE FROM THE UTILISATION OF BIOSIMILAR INFLIXIMAB IN THE IRISH SECONDARY CARE SETTING",

keywords = "Biosimilar, Infliximab, Medicine, Irish, Health care, Actuarial science, Business, Disease, Economics, Internal medicine, Linguistics, Philosophy, Economic growth",

author = "Mark Mulcahy",

year = "2018",

doi = "10.1016/j.jval.2018.09.876",

language = "English",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - PGI34 - A COST SAVING MEASURE FROM THE UTILISATION OF BIOSIMILAR INFLIXIMAB IN THE IRISH SECONDARY CARE SETTING

AU - Mulcahy, Mark

PY - 2018

Y1 - 2018

KW - Biosimilar

KW - Infliximab

KW - Medicine

KW - Irish

KW - Health care

KW - Actuarial science

KW - Business

KW - Disease

KW - Economics

KW - Internal medicine

KW - Linguistics

KW - Philosophy

KW - Economic growth

U2 - 10.1016/j.jval.2018.09.876

DO - 10.1016/j.jval.2018.09.876

M3 - Article

SN - 1098-3015

JO - Value in Health

JF - Value in Health

ER -